Literature DB >> 671222

Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

K Yamaoka, T Nakagawa, T Uno.   

Abstract

Mesh：

Substances：

Year:  1978        PMID： 671222     DOI： 10.1007/BF01117450

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN： 0090-466X


× No keyword cloud information.
  6 in total

1.  Linear pharmacokinetic models and vanishing exponential terms: implications in pharmacokinetics.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1976-10

2.  Statistical estimations in pharmacokinetics.

Authors:  H G Boxenbaum; S Riegelman; R M Elashoff
Journal:  J Pharmacokinet Biopharm       Date:  1974-04

3.  Comparative pharmacokinetics of coumarin anticoagulants. IV. Application of a three-compartmental model to the analysis of the dose-dependent kinetics of bishydroxycoumarin elimination.

Authors:  R Nagashima; G Levy; R A O'Reilly
Journal:  J Pharm Sci       Date:  1968-11       Impact factor: 3.534

4.  Pharmacokinetic profile of diazepam in man following single intravenous and oral and chronic oral administrations.

Authors:  S A Kaplan; M L Jack; K Alexander; R E Weinfeld
Journal:  J Pharm Sci       Date:  1973-11       Impact factor: 3.534

5.  Pharmacokinetic profile of sulfisoxazole following intravenous, intramuscular, and oral administration to man.

Authors:  S A Kaplan; R E Weinfeld; C W Abruzzo; M Lewis
Journal:  J Pharm Sci       Date:  1972-05       Impact factor: 3.534

6.  Pharmacokinetic analysis on the disappearance of ethoxybenzamide from plasma. Statistical treatment of data of two compartmental model by a digital computer.

Authors:  H Nogami; M Hanano; S Awazu; H H Moon
Journal:  Chem Pharm Bull (Tokyo)       Date:  1969-10       Impact factor: 1.645
  6 in total
  450 in total

1.  Rate of change of blood concentrations is a major determinant of the pharmacodynamics of midazolam in rats.

Authors:  A Cleton; D Mazee; R A Voskuyl; M Danhof
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  Population pharmacokinetics of methadone in opiate users: characterization of time-dependent changes.

Authors:  A Rostami-Hodjegan; K Wolff; A W Hay; D Raistrick; R Calvert; G T Tucker
Journal:  Br J Clin Pharmacol       Date:  1999-07       Impact factor: 4.335

3.  Pharmacological basis for concentration-controlled therapy with zidovudine, lamivudine, and indinavir.

Authors:  T N Kakuda; L M Page; P L Anderson; K Henry; T W Schacker; F S Rhame; E P Acosta; R C Brundage; C V Fletcher
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

4.  Absorption kinetics after inhalation of fluticasone propionate via the Diskhaler, Diskus and metered-dose inhaler in healthy volunteers.

Authors:  C Brindley; C Falcoz; A E Mackie; A Bye
Journal:  Clin Pharmacokinet       Date:  2000       Impact factor: 6.447

5.  Some pharmacokinetic parameters and dosage regimens for a long-acting formulation of oxytetracycline in 6- to 8-month-old male calves.

Authors:  R Kumar; J K Malik
Journal:  Vet Res Commun       Date:  1998-12       Impact factor: 2.459

6.  Pharmacokinetics of oleandomycin in dogs after intravenous or oral administration alone and after pretreatment with metamizole or dexamethasone.

Authors:  A Milanova; L Lashev
Journal:  Vet Res Commun       Date:  2002-01       Impact factor: 2.459

7.  Rational dose selection for a nonnucleoside reverse transcriptase inhibitor through use of population pharmacokinetic modeling and Monte Carlo simulation.

Authors:  G L Drusano; K H P Moore; J P Kleim; W Prince; A Bye
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

8.  Quantitative evaluation of capacity-limited hepatobiliary transport based on hepatocellular diffusion model by MULTI(FEM).

Authors:  M Higashimori; K Yamaoka; S Fujitani; T Nakagawa
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-10       Impact factor: 2.745

9.  Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers.

Authors:  P D Knoester; D M Jonker; R T M Van Der Hoeven; T A C Vermeij; P M Edelbroek; G J Brekelmans; G J de Haan
Journal:  Br J Clin Pharmacol       Date:  2002-05       Impact factor: 4.335

10.  Integrated modelling of the clinical pharmacokinetics of SDZ HTF 919, a novel selective 5-HT4 receptor agonist, following oral and intravenous administration.

Authors:  S Appel-Dingemanse; M O Lemarechal; A Kumle; M Hubert; E Legangneux
Journal:  Br J Clin Pharmacol       Date:  1999-05       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.